Clinical Trials for Pomalidomide (POM)(CC-4047)

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCHEM12107
03/31/2013
A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of Pomalidomide (POM), Bortezomib (BTZ) and Low-Dose Dexamethasone (LD-DEX) versus Bortezomib and Low-Dose Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma (MM)

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.